EssilorLuxottica SA

EssilorLuxottica launches AI‑powered Ray‑Ban smart glasses with Meta, aiming to capture $25.9 billion smart‑glasses market by 2028 while navigating reimbursement and operational challenges.

EssilorLuxottica’s partnership with Meta brings AI‑enabled prescription smart glasses to market—boosting visual clarity, reducing eye strain, and meeting FDA & EU safety standards for everyday use.

EssilorLuxottica faces U.S. class‑action suits over disputed tariffs, with implications for pricing, supply chains and patient costs. Learn how the legal battle could reshape eyewear affordability and industry practices.

EssilorLuxottica boosts smart‑glasses sales with Meta, driving 7M units while buying back shares to reward investors and strengthen its hybrid fashion‑tech strategy.

EssilorLuxottica’s family‑owned stake may consolidate to 60 %+ under the founder’s son, reshaping board independence, R&D focus, and regulatory scrutiny while still ensuring safety‑centric eyewear standards for global markets.

Apple’s rumored smart‑glass move rattles EssilorLuxottica shares, sparking debate on tech‑industry disruption and family‑ownership shifts in the global eyewear market.

EssilorLuxottica’s modest share rise on Feb 16, 2026, signals strong market confidence, while its own‑share transaction hints at value creation amid expected European easing.

EssilorLuxottica’s new share‑buyback signals confidence, while its cutting‑edge lens tech and strict safety compliance promise sustained growth in the global eyewear market.

EssilorLuxottica to disclose share‑transaction details on Feb 17, boosting transparency amid European market caution, while analysts maintain a bullish outlook on its premium eyewear leadership.

EssilorLuxottica’s share‑buyback, record Q4 earnings, and bullish analyst view signal confident growth and higher shareholder returns.